High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats

被引:30
作者
Conti, M
Renaud, IM
Poirier, B
Michel, O
Belair, MF
Mandet, C
Bruneval, P
Myara, I
Chevalier, J
机构
[1] Hop Bicetre, Biochem Lab, F-94270 Le Kremlin Bicetre, France
[2] Hop Broussais, INSERM, U430, F-75014 Paris, France
[3] Claude Bernard Assoc, F-75005 Paris, France
[4] Charles Foix Hosp, Biochem Lab, F-94205 Ivry, France
[5] Fac Pharmaceut & Biol Sci, Lab Appl Biochem, F-92296 Chatenay Malabry, France
关键词
left ventricular hypertrophy; renal failure; oxidative stress; Zucker rats; hyperlipidemia;
D O I
10.1152/ajpregu.00521.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Chronic renal failure often induces left ventricular hypertrophy. We assessed whether the heart is affected in the Zucker obese rat, a model of chronic renal failure associated with obesity, glucose intolerance, and insulin resistance without hypertension or hyperglycemia. After systemic blood pressure measurement, the heart, the aorta, and the kidneys were removed from anesthetized 9- and 13-mo-old Zucker obese and lean control male rats ( n = 33, n = 24, n = 25, and n = 21, respectively). Determination of left ventricular geometry, quantification of myocardium collagen density, and measurement of heart antioxidant enzyme activity were made, as well as aorta and kidney parameters. Mean blood pressure remained at a normal range whatever the age and group considered. Whereas kidney structure and function were severely impaired, no sign of myocardial infarction or inflammatory process was noticed. A moderate left ventricular hypertrophy was observed in 13-mo-old obese rats. While heart malondialdehyde was stable with age and among groups, antioxidant enzyme activity was higher in obese rats. In conclusion, in the absence of hypertensive or hyperglycemic disorders, the heart seems to display a sufficient line of defense against oxidative stress during the development of cardiac hypertrophy.
引用
收藏
页码:R793 / R800
页数:8
相关论文
共 61 条
[1]   THE CARDIOMYOPATHY OF OBESITY [J].
ALEXANDER, JK .
PROGRESS IN CARDIOVASCULAR DISEASES, 1985, 27 (05) :325-334
[2]   Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome [J].
Alpert, MA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2001, 321 (04) :225-236
[3]   OBESITY AND THE HEART [J].
ALPERT, MA ;
HASHIMI, MW .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1993, 306 (02) :117-123
[4]  
*AM PHYS SOC, 2002, AM J PHYSIOL-REG I, V283, pR281, DOI DOI 10.1152/AJPREGU.00279.2002
[5]   REDUCED CAPILLARY DENSITY IN THE MYOCARDIUM OF UREMIC RATS - A STEREOLOGICAL STUDY [J].
AMANN, K ;
WIEST, G ;
ZIMMER, G ;
GRETZ, N ;
RITZ, E ;
MALL, G .
KIDNEY INTERNATIONAL, 1992, 42 (05) :1079-1085
[6]  
BOGIN E, 1981, J CLIN INVEST, V67, P1215, DOI 10.1172/JCI110137
[7]  
BOGIN E, 1982, MINER ELECTROL METAB, V7, P151
[8]   Health hazards of obesity [J].
Bray, GA .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1996, 25 (04) :907-+
[9]  
Choudhury L, 1997, EUR HEART J, V18, P108
[10]  
CONTI M, 1991, CLIN CHEM, V37, P1273